MacQS: A Novel Synthetic Immune Cell Therapy for Biofilm Eradication in Cystic Fibrosis
Regional Winner
Health and well-being
Regional Winner
Health and well-being
Submitted by
Krish Mendapara
Share
Year
2025
Category
Health and well-being
Region
Ontario
Project description
MacQS is a novel synthetic immune cell therapy designed to target Pseudomonas aeruginosa – a leading cause of Cystic Fibrosis. Current. MacQS disrupts bacterial persistence by offering lab-developed and research-driven therapy.
